In this pivotal role, you will be the strategic regulatory voice across Project Teams, defining global regulatory strategies for innovative medicines—including small molecules, biologics, and radiopharmaceuticals—from first-in-human studies through to registration.
Together, we innovate, we impact, we grow ! At Debiopharm, every step we take is guided by one purpose: improving the lives of people affected by cancer and infectious diseases. As a privately-owned Swiss biopharmaceutical company, we’re driven by science, but above all, by the people behind every treatment — the patients and their families. Through our unique “development only” model, we bring forward promising therapies and transform them into treatments that can reach those who need them most, faster.
